The GRF peptide is said to have the similar potency and efficacy as that of tesamorelin and is shorter than it.
Tesamorelin is an analogue of the human growth-hormone releasing which reduces excess abdominal fat in HIV-infected patients with lipodystrophy
Theratechnologies vice-resident research Krishna Peri said the discovery of GRF peptides with improved pharmaceutical properties and similar potency and efficacy to tesamorelin gives way to alternative routes of drug delivery.